NGM Biopharmaceuticals, Inc.
BISPECIFIC ANTIBODIES
Last updated:
Abstract:
The present disclosure relates to multispecific binding agents, in particular tetravalent bispecific antibodies, related polynucleotides, vectors, host cells, compositions, and methods of producing the binding agents.
Status:
Application
Type:
Utility
Filling date:
2 Jul 2019
Issue date:
19 Aug 2021